Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 8;15(3):248-256.
doi: 10.7150/ijms.22891. eCollection 2018.

Recent insights into mitochondrial targeting strategies in liver transplantation

Affiliations
Review

Recent insights into mitochondrial targeting strategies in liver transplantation

Rui Miguel Martins et al. Int J Med Sci. .

Abstract

Ischemia/reperfusion (I/R) injury in liver transplantation can disrupt the normal activity of mitochondria in the hepatic parenchyma. This potential dysfunction of mitochondria after I/R injury could be responsible for the initial poor graft function or primary nonfunction observed after liver transplantation. Thus, determining the mechanisms that lead to human hepatic mitochondrial dysfunction might contribute to improving the outcome of liver transplantation. Furthermore, early identification of novel prognostic factors involved in I/R injury could serve as a key endpoint to predict the outcome of liver grafts and also to promote the early adoption of novel strategies that protect against I/R injury. Here, we briefly review recent advances in the study of mitochondrial dysfunction and I/R injury, particularly in relation to liver transplantation. Next, we highlight various pharmacological therapeutic strategies that could be applied, and discuss their relationship to relevant mitochondrion-related processes and targets. Lastly, we note that although considerable progress has been made in our understanding of I/R injury and mitochondrial dysfunction, further investigation is required to elucidate the cellular and molecular mechanisms underlying these processes, thereby identifying biomarkers that can help in evaluating donor organs.

Keywords: Ischemia/reperfusion injury; Liver preservation solution; Liver transplantation; Mitochondria; Pharmacological conditioning.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Schematic timeline of the liver transplantation phases of I/R injury.
Figure 2
Figure 2
I/R injury caused by cold ischemia and warm ischemia can produce common and specific effects on various subsets of cells. For example, sinusoidal endothelial cells are more susceptible than hepatic parenchymal cells to the effects of cold preservation, and the reperfusion phase amplifies the ischemic injury with the preferential involvement of the hepatic parenchymal cells; A- space of Disse; B- sinusoid; C- sinusoidal endothelial cells (with fenestrae); D- biliary canaliculus; E- Stellate cell; F- Kupffer cell; H- hepatocyte; N- nucleus.
Figure 3
Figure 3
Mitochondrion-related processes and targets
Figure 4
Figure 4
Interaction between the regulation of gene expression by RNA interference due to the presence of pre-mature (pre-miRNA) and mature (miRNA) microRNAs and the mitochondria system

References

    1. Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation. 2002;73:493–9. - PubMed
    1. Jassem W, Battino M, Cinti C, Norton SJ, Saba V, Principato G. Biochemical changes in transplanted rat liver stored in University of Wisconsin and Euro-Collins solutions. The Journal of surgical research. 2000;94:68–73. - PubMed
    1. Jaeschke H, Woolbright BL. Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplantation reviews. 2012;26:103–14. - PMC - PubMed
    1. Go KL, Lee S, Zendejas I, Behrns KE, Kim JS. Mitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion Injury. BioMed research international. 2015;2015:183469. - PMC - PubMed
    1. Varela AT, Rolo AP, Palmeira CM. Fatty liver and ischemia/reperfusion: are there drugs able to mitigate injury? Current medicinal chemistry. 2011;18:4987–5002. - PubMed

MeSH terms

Substances